Home » Topics » Conferences

Conferences
RSS

YM-60828: an orally active factor Xa inhibitor from Yamanouchi

Sep. 11, 1997

New atypical antipsychotic agent from HMR

Sep. 11, 1997

LG Chemical characterizes new thrombin inhibitor

Sep. 10, 1997

SAR reported by Parke-Davis for series of N-type Ca2+ antagonists

Sep. 10, 1997

Resveratrol found in edible peanuts

Sep. 9, 1997

Ethnic differences in codeine's efficacy/side effects

Sep. 9, 1997

Voglibose preclinical results described at Japanese congress

Sep. 8, 1997

Sleep-promoting effects of L-846 demonstrated in insomniac patients

Sep. 8, 1997

Spotlight on adenosine A1 receptor agonists

Sep. 4, 1997

DANAMI trial results presented

Sep. 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...